Health Trials

Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma

This is an open label Phase 2 study to evaluate the efficacy and safety of ACR-368 as monotherapy or with ultra-low dose gemcitabine (ULDG) sensitization in participants with endometrial cancer.

Participants needed: 350
Trial details
Phase: Phase 2Age: 18+Biological sex: FemaleType: InterventionalSponsor: Acrivon TherapeuticsUpdated: Jun 15, 2026Locations: 91
Eligibility criteria

Participant must be able to give signed, written informed consent. [+27]

Participant with known symptomatic brain metastases requiring > 10 mg/day of pre... [+11]

Read more
Status: Recruiting

Phase 1 Study of ACR-2316 in Specific Advanced Solid Tumors

This is a first in-human, Open-label Phase 1 study to assess the safety of ACR-2316 for the treatment of subjects with specific, histologically confirmed, locally advanced, recurrent or metastatic solid tumors.

Participants needed: 100
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Acrivon TherapeuticsUpdated: Mar 23, 2026Locations: 15
Eligibility criteria

Signed written informed consent. [+7]

Participants with known symptomatic brain metastases. [+4]

Read more